129 related articles for article (PubMed ID: 1904052)
1. Interferon alpha induces expression of the CD69 activation antigen in human resting NK cells, while interferon gamma and tumor necrosis factor alpha are ineffective.
Gerosa F; Scardoni M; Tommasi M; Benati C; Snelli L; Gandini G; Libonati M; Tridente G; Carra G
Int J Cancer; 1991 May; 48(3):473-5. PubMed ID: 1904052
[No Abstract] [Full Text] [Related]
2. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Jewett A; Bonavida B
Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 1998 May; 12(5):1165-70. PubMed ID: 9538144
[TBL] [Abstract][Full Text] [Related]
5. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell response to interferons.
Abbud-Filho M; Ransil BJ; Kelley VE; Fiers W; Strom TB
Clin Immunol Immunopathol; 1986 May; 39(2):264-76. PubMed ID: 3084143
[TBL] [Abstract][Full Text] [Related]
7. Different sensitivity to interleukin 4 of interleukin 2- and interferon alpha-induced CD69 antigen expression in human resting NK cells and CD3+, CD4-, CD8- lymphocytes.
Gerosa F; Tommasi M; Carra G; Gandini G; Tridente G; Benati C
Cell Immunol; 1992 May; 141(2):342-51. PubMed ID: 1533569
[TBL] [Abstract][Full Text] [Related]
8. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
Kim YB; Chung TJ
Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
[No Abstract] [Full Text] [Related]
11. Phenotypic analysis of PBMCs from uterine cervix cancer patients with high natural killer activity.
Pinel MI; Pires V; Harab RC; Rumjanek VM
J Clin Lab Immunol; 1997; 49(2):83-9. PubMed ID: 9819676
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.
Une C; Grönberg A; Axberg I; Jondal M; Orn A
Cell Immunol; 1991 Mar; 133(1):127-37. PubMed ID: 1703925
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.
Esplugues E; Vega-Ramos J; Cartoixà D; Vazquez BN; Salaet I; Engel P; Lauzurica P
Blood; 2005 Jun; 105(11):4399-406. PubMed ID: 15692061
[TBL] [Abstract][Full Text] [Related]
14. Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.
Poggi A; Prevosto C; Massaro AM; Negrini S; Urbani S; Pierri I; Saccardi R; Gobbi M; Zocchi MR
J Immunol; 2005 Nov; 175(10):6352-60. PubMed ID: 16272287
[TBL] [Abstract][Full Text] [Related]
15. Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon alpha or gamma, human recombinant interleukin-2 and indomethacin.
Conti P; Reale M; Angeletti PU; Dinarello CA
Int J Immunopharmacol; 1988; 10(8):907-11. PubMed ID: 3145923
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
Ostensen ME; Thiele DL; Lipsky PE
J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the early activation antigen CD69 in murine macrophages.
Marzio R; Jirillo E; Ransijn A; Mauël J; Corradin SB
J Leukoc Biol; 1997 Sep; 62(3):349-55. PubMed ID: 9307073
[TBL] [Abstract][Full Text] [Related]
18. Structure and functions of gamma-dodecalactone isolated from Antrodia camphorata for NK cell activation.
Chen CJ; Vijaya Krishna R; Tsai CC; Wu WH; Chao LK; Hwang KH; Chien CM; Chang HY; Chen ST
Bioorg Med Chem; 2010 Sep; 18(18):6896-904. PubMed ID: 20708940
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
20. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
